Word

VAMYLIO

Status

Pending

Status Code

630

Status Date

Thursday, April 4, 2024

Serial Number

79392815

Mark Type

5000

Filing Date

Friday, February 2, 2024

Trademark Owner History

Prothena Biosciences Limited

Classifications

5 Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes

45 Licensing of intellectual property in the field of biotechnology

42 Research and development in the pharmaceutical and biotechnology fields

Trademark Events

Apr 9, 2024

Application Filing Receipt Mailed

Apr 5, 2024

New Application Office Supplied Data Entered

Apr 4, 2024

Sn Assigned For Sect 66a Appl From Ib